Fang Misa, Koneru Manisha, Oliveira Renato, Santucci Joshua, Patel Pratit, Khalife Jane, Shaikh Hamza A, Tonetti Daniel A
Cooper Medical School of Rowan University, Camden, New Jersey.
Departments of Neurology, Cooper University Health Care, Camden, New Jersey.
J Neurosurg Case Lessons. 2024 Oct 28;8(18). doi: 10.3171/CASE24296.
Iatrogenic vertebral artery injury during surgery can cause pseudoaneurysm, hemorrhage, thrombosis, ischemia, or death. Strategies to prevent cerebrovascular embolic complications include surgical ligation, endovascular stenting, and/or antiplatelet therapy.
A 73-year-old female with a known right vertebral artery occlusion underwent a C2-3 laminectomy, complicated by left vertebral artery injury and occlusion with subsequent posterior circulation ischemia. She underwent immediate angioplasty and stenting of the injured artery with undersized drug-eluting stents. Dual antiplatelet therapy of aspirin 81 mg daily and ticagrelor 90 mg twice daily was initiated. On two occasions, more than 6 months after stenting, holding a single ticagrelor dose led to in-stent thrombosis and embolic stroke within hours of the missed dose. Lifelong therapy with ticagrelor was favored over further procedural intervention.
It is recommended to prioritize optimal wall stent apposition with oversized stents in patients without collateral circulation. The risk of thromboembolism due to poorly apposed stents is very high, even in delayed (> 6 months) settings. Stent construct revision or bypass grafting may not be feasible or desirable options. For patients without wall apposition, endothelialization may not occur, necessitating lifelong P2Y12 inhibitor therapy to prevent recurrent thromboembolic events. https://thejns.org/doi/10.3171/CASE24296.
手术期间医源性椎动脉损伤可导致假性动脉瘤、出血、血栓形成、缺血或死亡。预防脑血管栓塞并发症的策略包括手术结扎、血管内支架置入和/或抗血小板治疗。
一名73岁女性,已知右椎动脉闭塞,接受了C2 - 3椎板切除术,并发左椎动脉损伤和闭塞,随后出现后循环缺血。她立即接受了血管成形术,并使用尺寸过小的药物洗脱支架对受伤动脉进行了支架置入。开始每日服用81毫克阿司匹林和每日两次服用90毫克替格瑞洛的双重抗血小板治疗。在支架置入6个月以上的两次情况中,单次漏服替格瑞洛剂量导致在漏服剂量后的数小时内发生支架内血栓形成和栓塞性中风。与进一步的手术干预相比,更倾向于使用替格瑞洛进行终身治疗。
对于没有侧支循环的患者,建议优先使用尺寸过大的支架实现最佳的血管壁支架贴合。即使在延迟(>6个月)的情况下,支架贴合不良导致血栓栓塞的风险也非常高。支架结构修复或旁路移植可能不是可行或理想的选择。对于没有血管壁贴合的患者,可能不会发生内皮化,因此需要终身使用P2Y12抑制剂治疗以预防复发性血栓栓塞事件。https://thejns.org/doi/10.3171/CASE24296 。